Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.
Personeni N, Rimassa L, Verusio C, Barni S, Rubino L, Bozzarelli S, Villa E, Carnaghi C, Tronconi MC, Gerardi C, Galli F, Floriani I, Destro A, Raschioni C, Labianca R, Santoro A. Personeni N, et al. Among authors: gerardi c. Clin Colorectal Cancer. 2015 Sep;14(3):162-9. doi: 10.1016/j.clcc.2015.02.006. Epub 2015 Mar 6. Clin Colorectal Cancer. 2015. PMID: 25861836 Clinical Trial.
Recommendations for robust and reproducible preclinical research in personalised medicine.
Fosse V, Oldoni E, Bietrix F, Budillon A, Daskalopoulos EP, Fratelli M, Gerlach B, Groenen PMA, Hölter SM, Menon JML, Mobasheri A, Osborne N, Ritskes-Hoitinga M, Ryll B, Schmitt E, Ussi A, Andreu AL, McCormack E; PERMIT group. Fosse V, et al. BMC Med. 2023 Jan 8;21(1):14. doi: 10.1186/s12916-022-02719-0. BMC Med. 2023. PMID: 36617553 Free PMC article. Review.
Diagnostic performance of contrast-enhanced ultrasound (CEUS) and contrast-enhanced endoscopic ultrasound (ECEUS) for the differentiation of pancreatic lesions: a systematic review and meta-analysis.
D'Onofrio M, Biagioli E, Gerardi C, Canestrini S, Rulli E, Crosara S, De Robertis R, Floriani I. D'Onofrio M, et al. Among authors: gerardi c. Ultraschall Med. 2014 Dec;35(6):515-21. doi: 10.1055/s-0034-1385068. Epub 2014 Sep 16. Ultraschall Med. 2014. PMID: 25226455 Review.
Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
Buda A, Lissoni AA, Floriani I, Biagioli E, Gerardi C, Bonazzi C, Chiari S, Locatelli L, Dell'Anna T, Signorelli M, Mangioni C, Milani R. Buda A, et al. Among authors: gerardi c. Int J Gynecol Cancer. 2015 Oct;25(8):1468-75. doi: 10.1097/IGC.0000000000000515. Int J Gynecol Cancer. 2015. PMID: 26222484
Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study.
La Verde N, Biagioli E, Gerardi C, Cordovana A, Casiraghi C, Floriani I, Bernardin E, Farina G, Di Cosimo S, Dazzani MC, Gherardi G. La Verde N, et al. Among authors: gerardi c. Springerplus. 2016 Feb 3;5:114. doi: 10.1186/s40064-016-1720-9. eCollection 2016. Springerplus. 2016. PMID: 26885467 Free PMC article.
Quality of Life in Glaucoma: A Review of the Literature.
Quaranta L, Riva I, Gerardi C, Oddone F, Floriani I, Konstas AG. Quaranta L, et al. Among authors: gerardi c. Adv Ther. 2016 Jun;33(6):959-81. doi: 10.1007/s12325-016-0333-6. Epub 2016 Apr 30. Adv Ther. 2016. PMID: 27138604 Free PMC article. Review.
Erratum to: Quality of Life in Glaucoma: A Review of the Literature.
Quaranta L, Riva I, Gerardi C, Oddone F, Floriani I, Konstas AG. Quaranta L, et al. Among authors: gerardi c. Adv Ther. 2016 Jun;33(6):982. doi: 10.1007/s12325-016-0342-5. Adv Ther. 2016. PMID: 27167620 Free PMC article. No abstract available.
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer.
Colombo N, Zaccarelli E, Baldoni A, Frezzini S, Scambia G, Palluzzi E, Tognon G, Lissoni AA, Rubino D, Ferrero A, Farina G, Negri E, Pesenti Gritti A, Galli F, Biagioli E, Rulli E, Poli D, Gerardi C, Torri V, Fossati R, D'Incalci M. Colombo N, et al. Among authors: gerardi c. Br J Cancer. 2019 Oct;121(9):744-750. doi: 10.1038/s41416-019-0584-5. Epub 2019 Sep 20. Br J Cancer. 2019. PMID: 31537908 Free PMC article. Clinical Trial.
152 results